CYP46A1 and Alzheimer disease: Pharmacological activation of CYP46A1 with efavirenz in male and female AD mouse models ameliorated spatial memory (19) and familial human AD induced pluripotent stem cell (iPSC)–derived neurons treated with efavirenz showed decreased Aβ secretion and Tau phosphorylation (20).